Fever-Reducer Extends Illness

Multivariate analysis suggested that antipyretic therapy prolonged illness in subjects infected with influenza A, but its use was the result of prolonged illness in those infected with S. sonnei. The precise nature of these relationships requires a prospective, randomized, placebo-controlled trial.

 Fever Reducing Medicines Increase the Spread of Infection

To put our lower bound for fp into perspective, consider that approximately 41 400 (95% CI: 27 100–55 700) deaths per year are attributed to seasonal influenza epidemics in the United States [43] (and an order of magnitude more worldwide [44]). Taken at face value, our results indicate, for example, that if Embedded Image then at least 700 deaths per year (95% CI: 30–2100) (and many more serious illnesses) could be prevented in the US alone by avoiding antipyretic medication for the treatment...